Skip to Content
Merck
All Photos(1)

Key Documents

PHR1362

Supelco

Calcium Acetate

Pharmaceutical Secondary Standard; Certified Reference Material

Synonym(s):

Calcium acetate

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
(CH3CO2)2Ca
CAS Number:
Molecular Weight:
158.17
EC Number:
MDL number:
UNSPSC Code:
41116107
PubChem Substance ID:
NACRES:
NA.24

grade

certified reference material
pharmaceutical secondary standard

Quality Level

Agency

traceable to USP 1086334

API family

calcium acetate

CofA

current certificate can be downloaded

technique(s)

HPLC: suitable
gas chromatography (GC): suitable

impurities

~1% Acetic acid

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-30°C

SMILES string

CC(=O)O[Ca]OC(C)=O

InChI

1S/2C2H4O2.Ca/c2*1-2(3)4;/h2*1H3,(H,3,4);/q;;+2/p-2

InChI key

VSGNNIFQASZAOI-UHFFFAOYSA-L

Looking for similar products? Visit Product Comparison Guide

General description

Calcium Acetate belongs to the group of calcium salts, widely used as phosphorus binders in patients with chronic renal failure.
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.

Application

These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.

Footnote

To see an example of a Certificate of Analysis for this material enter LRAA1466 in the slot below. This is an example certificate only and may not be the lot that you receive.

related product

Storage Class Code

11 - Combustible Solids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Tin Wui Wong et al.
Drug development and industrial pharmacy, 38(12), 1417-1427 (2012-02-09)
Alginate-chitosan pellets prepared by extrusion-spheronization technique exhibited fast drug dissolution. This study aimed to design sustained-release alginate pellets through rapid in situ matrix coacervation by chitosan during dissolution. Pellets made of alginate with chitosan and/or calcium acetate were prepared using
Geoffrey A Block et al.
Journal of the American Society of Nephrology : JASN, 23(8), 1407-1415 (2012-07-24)
Some propose using phosphate binders in the CKD population given the association between higher levels of phosphorus and mortality, but their safety and efficacy in this population are not well understood. Here, we aimed to determine the effects of phosphate
Melanie Gorman Ng et al.
The Annals of occupational hygiene, 57(5), 627-639 (2013-01-15)
Although dustiness and viscosity are potential determinants of dermal exposure, their effect on exposure is poorly understood. The goal of this study was to investigate the effect of dustiness and viscosity on dermal exposure by each of three dermal exposure
Juan F Navarro-González et al.
Clinical journal of the American Society of Nephrology : CJASN, 6(9), 2272-2279 (2011-07-26)
Hyperphosphatemia and subclinical endotoxemia are important sources of inflammation in HD. Proinflammatory cytokines are strong correlates of soluble CD14 (sCD14) concentrations, an independent predictor of mortality in this population. We evaluated the effects of calcium acetate and sevelamer hydrochloride on
Rodrigo B de Oliveira et al.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 28(10), 2510-2517 (2013-08-27)
Mineral bone disorder (MBD) is an early complication of chronic kidney disease (CKD), with complex interactions in the bone-kidney-energy axis. These events lead to impaired bone remodelling, which in turn is associated with cardiovascular disease. Recently, we reported on a

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service